ClinicalTrials.gg
Sign In

Signs and Symptoms clinical trials

The registry lists 221 studies for Signs and Symptoms across more than 10 countries. 22 are recruiting or about to start. 44 of them are mainly about Signs and Symptoms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 327 narrower conditions too, such as Obesity: 81,254 studies, 15,907 open.

Get an email when these change. Save the Signs and Symptoms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
137
Status unknown
30
Recruiting
15
Terminated
14
Withdrawn
11
Not yet recruiting
7

Phase

Phase 3
23
Phase 2
20
Phase 4
12
Phase 1
10

Where

United States
80
Turkey
17
Germany
16
France
14
Italy
14
Canada
14

Who runs them

University of California, San Francisco (5) · Vanderbilt University Medical Center (4) · Danish Headache Center (4) · Millet Innovation (4) · University of California, Irvine (4) · OHSU Knight Cancer Institute (3) · Auspex Pharmaceuticals, Inc. (3) · UNC Lineberger Comprehensive Cancer Center (3)

What is being tested here

Drugs under test in Signs and Symptoms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Islet Amyloid Polypeptide202
Berobenatide122
Honey101
Propolis101
Adrenomedullin101
Dexmedetomidine101
Deutetrabenazine033
Gefapixant022
Brimapitide022
Chlorpheniramine022

Coming up

2phase 3 studies under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 15 Signs and Symptoms studies recruiting now, 9 (60%) set no upper age limit and 3 (20%) stop at 75 or younger. 1 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (20%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
100 (0%)0 (0%)
1814 (93%)14 (93%)
3013 (87%)13 (87%)
4013 (87%)13 (87%)
5013 (87%)13 (87%)
6514 (93%)14 (93%)
7512 (80%)12 (80%)
859 (60%)9 (60%)

Across all 221 studies, recruiting or not: 30% stop at 75 or younger and 24% at 65; 14% take children; 11% are for women only and 2% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Signs and Symptoms studies take

Of 69 interventional studies with no phase under Signs and Symptoms, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo6–37 · 69 studies—22 mo8–37 · 58 studies
Observational16 mo8–20 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 221. Browse all 221 → or search them.